TORONTO, ON / ACCESSWIRE / February 8, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynami...Read More
TORONTO, ON / ACCESSWIRE / February 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynami...Read More
(TheNewswire) Toronto, Ontario – TheNewswire -- January 25th, 2024 – Tantalex Lithium Resources Corp. (CSE:TTX) (FSE:DW8) (OTC:TTLXF) (“Tantalex” or the “Corporation”) is pleased to announce that its TiTan tin and tantalum alluvial plant has now produce...Read More
TORONTO, ON / ACCESSWIRE / January 15, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Phot...Read More
Toronto, Ontario--(Newsfile Corp. - January 15, 2024) - Tantalex Lithium Resources Corp (CSE: TTX) (FSE: DW8) is pleased to announce the company is participating in the upcoming 121 Mining Investment Conference in Cape Town. 121 Mining Investment Cape Town will be hosting over 125 mining compani...Read More
(TheNewswire) Toronto, Ontario - TheNewswire - December 15, 2023 - Tantalex Lithium Resources Corp. (CSE:TTX) (FSE:DW8) (OTC:TTLXF) (“Tantalex” or the “Corporation”) is pleased to announce operational and corporate updates. Manono Lithium Tailings Project &#...Read More
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dyna...Read More
TORONTO, ON / ACCESSWIRE / November 29th, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dyn...Read More
TORONTO, ON / ACCESSWIRE / November 17, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynam...Read More
(TheNewswire) Toronto, Ontario - TheNewswire - November 13th, 2023 – Tantalex Lithium Resources Corp. (CSE:TTX) – (FSE:DW8) – (OTC:TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce it has concluded a lithium marketing off...Read More
Post Study II Monitoring of Response, Optional Maintenance Study II Treatments and Central Pathology Laboratory Review OptimizedTORONTO, ON / ACCESSWIRE / October 23, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a...Read More
(TheNewswire) Toronto, Ontario - TheNewswire - October 23rd, 2023 – Tantalex Lithium Resources Corp. (CSE:TTX) – (FSE:DW8) – (OTC:TTLXF) (“Tantalex” or the “Corporation”), is pleased to report it has filed its NI 43-101 Preliminary Econ...Read More
TORONTO, ON / ACCESSWIRE / October 23, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynami...Read More
Theralase®'s Latest Clinical Data Demonstrates 65% of Patients Treated with Theralase®'s Anti-Cancer Therapy Achieved a Complete ResponseTORONTO, ON / ACCESSWIRE / October 16, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TL...Read More
(NewsDirect) Tantalex Lithium CEO Eric Allard joined Steve Darling from Proactive to share news the company has unveiled the preliminary economic assessment (PEA) for the Manono Lithium Tailings Project in the Democratic Republic of Congo.Allard highlighted the positive findings of the PEA, which i...Read More
VANCOUVER, BC / ACCESSWIRE / October 10, 2023 / The Watchlist by The Market Herald has announced the release of new interviews with Copper Lake Resources, Tantalex Lithium, Ucore Rare Metals, and Marvel Discovery Corp., providing insights into their latest developments.The Watchlist by The M...Read More
(TheNewswire) Key PEA Highlights Excellent project economics and financial returns Robust pre-tax NPV10%of approximately $764 million and 87.4% IRR on a nominal basis, and a pre-tax NPV10%of approximately $638 million and 82.3% IRR on a real basis. Rapidpaybackof1 y...Read More
TORONTO, ON / ACCESSWIRE / September 27, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and radiation activatedPhot...Read More
(TheNewswire) Toronto, Ontario - TheNewswire - September 22, 2023 – Tantalex Lithium Resources Corp. (CSE:TTX) – (FSE:DW8) – (OTC:TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce the closing of its continued non-brokered priva...Read More
TORONTO, ON / ACCESSWIRE / September 21, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (&...Read More